Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to rise 33.02% to -65 cents per share on October 27
Q3'22
Est.
$-0.66
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.33
Q3'24
Beat
by $0.07
Q4'22
Beat
by $4.20
The last earnings report on May 15 showed earnings per share of -49 cents, missing the estimate of -42 cents. With 118.00 shares outstanding, the current market capitalization sits at 134.55M.